Evaluation of Biologics ACE2/Ang(1–7) Encapsulated in Plant Cells for FDA Approval: Safety and Toxicology Studies
<b>Background/Objectives:</b> For several decades, protein drugs (biologics) made in cell cultures have been delivered as sterile injections, decreasing their affordability and patient preference. Angiotensin Converting Enzyme 2 (ACE2) gum is the first engineered human blood protein expr...
Saved in:
Main Authors: | Henry Daniell, Geetanjali Wakade, Smruti K. Nair, Rahul Singh, Steven A. Emanuel, Barry Brock, Kenneth B. Margulies |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-12-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/17/1/12 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Volumetric Absorptive Microsampling in Toxicology
by: Bruno Pires, et al.
Published: (2024-12-01) -
Toxicological complexity of microplastics in terrestrial ecosystems
by: Fazal Ullah, et al.
Published: (2025-02-01) -
Editorial: Leveraging artificial intelligence and open science for toxicological risk assessment
by: Marc Teunis, et al.
Published: (2025-02-01) -
Editorial: Five grand challenges in toxicology
by: Bengt Fadeel, et al.
Published: (2025-01-01) -
Sleep quality among sample of Egyptian patients with Alzheimer’s disease: risk factors and role of genetic profiling for ACE, ACE 2 and APO E genotypes
by: Khaled Ahmed Elbeh, et al.
Published: (2025-01-01)